(Q28082036)

language of work or name

1 reference

May 2015

1 reference

1 reference

479-480

1 reference

PubMed

page(s)

379-92

1 reference

Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Evaluation of the neurovirulence test for mumps vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Vaccines, Crohn's disease and autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Genetic characterization of measles vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Attenuation of wild-type yellow fever virus by passage in HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Studies in smallpox and vaccination. 1913.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Emerging Concept of Poliomyelitis Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Detectionof reverse transcriptase activity in live attenuated virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Comparative monkey neurovirulence of sabin type III poliovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Genetic studies on a mumps vaccine strain associated with meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Measles antibody: reevaluation of protective titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Failure of live, attenuated oral rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Measles vaccines: a review of adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Propagation in tissue cultures of cytopathogenic agents from patients with measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Effectiveness of Lanzhou lamb rotavirus vaccine against hospitalized gastroenteritis: further analysis and update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Atypical measles in adolescent siblings 16 years after killed measles virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Genetic variability among yellow fever virus 17D substrains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Rotavirus vaccines: targeting the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Development and Evaluation of the Moraten Measles Virus Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Measles vaccines used in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

AN INVESTIGATION OF THE ETIOLOGY OF MUMPS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Small-Pox in Glasgow--1900-1902

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The molecular biology of poliovaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Neurovirulence tests of three 17D yellow fever vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Considerations for setting the specifications of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The polio-eradication programme and issues of the end game

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The Temperature Sensitivity of the Sabin Type 3 Vaccine Strain of Poliovirus: Molecular and Structural Effects of a Mutation in the Capsid Protein VP3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Measles: immune suppression and immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Antigenic segregation of type 3 poliovirus isolates related and unrelated to Sabin's vaccine strain with the use of modified Wecker and McBride techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The pathogenesis of poliomyelitis: what we don't know

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Vaccine-Associated Paralytic Poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Differences in the Appearance of Antibodies to Structural Components of Measles Virus after Immunization with Inactivated and Live Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Assessment of the ferret as an in vivo model for mumps virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Assay of humoral immunity to mumps virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Reverse transcriptase activity in vaccines derived from chick cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Pathogenesis of poliomyelitis; reappraisal in the light of new data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

History of Sabin attenuated poliovirus oral live vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Immune response and vaccine efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Human exposure to SV40: review and comment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

The use of yellow fever virus modified by in vitro cultivation for human immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Viral replication and development of specific immunity in macaques after infection with different measles virus strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Viscerotropic disease following yellow fever vaccination in Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

Antigenic and genetic variation of the HN protein of mumps virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

7 January 2021

LOSS IN VIRULENCE OF YELLOW FEVER VIRUS SERIALLY PASSED IN HELA CELLS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

7 January 2021

Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

7 January 2021

Comparative biochemical studies of type 3 poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

7 January 2021

Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine: report on a W.H.O. collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.032

7 January 2021

10.1016/J.VIROL.2015.03.032

Identifiers

DOI

0 references

PubMed publication ID

25864107

1 reference